Transfusion requirements and complication rate in β‐thalassemia intermedia due to heterozygous β‐globin gene mutation and triplicated α‐globin genes
European Journal of Haematology · 2023-11 · 111 (5) · 742-747
DOI: 10.1111/ejh.14070 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, online erschienen am 30.07.2023. Verfasst von Nathalie Bonello-Palot und 6 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille Univ, INSERM, MMG, AP-HM, Marseille, France. Hauptthemen laut MEDLINE: beta-Thalassemia, Thalassemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Maladies Constitutionnelles du Globule Rouge et de l'Erythropoïese.
Abstract (Originalsprache)
Introduction
The heterozygous condition for β‐thalassemia mutation associated with an extra functional α‐globin gene can produce a Thalassemia Intermedia (TI) phenotype. This genotype is the second in frequency in the French Thalassemia Registry NaThalY that prospectively collects laboratory and clinical data. Materials and Methods The present report analyses transfusion needs, iron overload (ferritin, hepatic and cardiac iron concentrations), and complication rates in 45 patients included in NaThalY and presenting a heterozygous β 0 or β + ‐thalassemia mutation associated with a triplication at HBA locus. This cohort was compared to a cohort of patients with TI due to mutations in the beta‐globin gene only and included in the French registry.
Results
Patients with an extra functional α‐globin gene showed a less severe anemia, lower transfusion needs and lower complication rates than those with TI related to the β‐globin gene only. Nevertheless, some of them displayed complications such as cholelithiasis or extramedullary hematopoiesis. In addition, one third of the cohort needed transfusions and another third was under iron chelation.
Conclusion
The genotype associating a heterozygous β 0 or β + ‐thalassemia mutation with a triplication at HBA locus should be accurately diagnosed as it could lead to symptomatic anemia and to potential iron overload and iron‐related complications even in patients with no transfusion need.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aix Marseille Univ, INSERM, MMG, AP-HM, Marseille, France.
- Registre NaThalY, AP-HM, Marseille, France.
- Centre de référence des maladies rares du globule rouge, Service d'hémato-oncologie pédiatrique, AP-HM, Marseille, France.
- Aix Marseille Univ, Service de recherche clinique et de statistique, Marseille, France.
ORCID-Profile: Nathalie Bonello-Palot, Audrey Benoit, Imane Agouti, Ilyes Hamouda, Valentine Brousse, Catherine Badens
Förderung
- Maladies Constitutionnelles du Globule Rouge et de l'Erythropoïese
Zitieren
APA
Bonello-Palot, N., Benoit, A., Agouti, I., Hamouda, I., Brousse, V., NaThalY Network, & Badens, C. (2023). Transfusion requirements and complication rate in β‐thalassemia intermedia due to heterozygous β‐globin gene mutation and triplicated α‐globin genes. European Journal of Haematology, 111(5), 742-747. https://doi.org/10.1111/ejh.14070
Vancouver
Bonello-Palot N, Benoit A, Agouti I, Hamouda I, Brousse V, NaThalY Network, et al. Transfusion requirements and complication rate in β‐thalassemia intermedia due to heterozygous β‐globin gene mutation and triplicated α‐globin genes. European Journal of Haematology. 2023;111(5):742-747. doi:10.1111/ejh.14070
BibTeX
@article{BonelloPalot2023,
author = {Bonello-Palot, Nathalie and Benoit, Audrey and Agouti, Imane and Hamouda, Ilyes and Brousse, Valentine and NaThalY Network, NaThalY Network and Badens, Catherine},
title = {Transfusion requirements and complication rate in β‐thalassemia intermedia due to heterozygous β‐globin gene mutation and triplicated α‐globin genes},
journal = {European Journal of Haematology},
year = {2023},
volume = {111},
number = {5},
pages = {742--747},
doi = {10.1111/ejh.14070}
}
EUVIMED